Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Performance variance reflects market swings and fund mechanics. This intro highlights how to interpret variation across periods.
27,234 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
OpenAI reports Codex downloads exceed 1 million with over 1 million weekly active users, signaling a shift toward Cod...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
Bittensor TAO surged over the past week, with chart chatter pointing to a possible breakout even as some indicators w...
BWET jumps 27.5% in the past month even as the S&P 500 declines, with UNG also rising and FCG offering a different ex...
Walmart stock faces a balanced 2026–2030 path, with growth from e-commerce and membership services battling cost pres...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
A Bay Area city mayor emerges as the lone pragmatic Democrat in California's governor race, drawing tech money and sp...
More than 100 amendments have been filed ahead of the Senate Banking Committee's markup on the Digital Asset Market C...
A new Gallup survey finds Americans would rather live near a nuclear plant than a data center, highlighting rising lo...
NEXA Lending launches a strategic investment and phased acquisition with Copper Ridge Ventures to expand its joint-ve...
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...